June 20, 2021

Volume XI, Number 171

Advertisement

June 18, 2021

Subscribe to Latest Legal News and Analysis

June 17, 2021

Subscribe to Latest Legal News and Analysis

Biotechnology, Life Sciences, Food and Drug Law News

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

Date Title Organization
5
Feb
Sounds Fishy: New Seafood Traceability Program Keller and Heckman LLP
5
Feb
Coalition for Affordable Drugs V LLC v. Biogen International GmbH - Denying Rehearing of Decision Not to Institute Based on Lack of Showing of Abuse of Discretion IPR2015-01086 Faegre Drinker
5
Feb
Behind the Curtain: Shkreli was NOT the Big Story on the Hill Today Mintz
4
Feb
FDA Places Ban on Import of GE Salmon Mintz
4
Feb
Food Safety: Consumer’s Point of View Keller and Heckman LLP
4
Feb
Asset Transferee Cannot Appeal Reexamination Foley & Lardner LLP
3
Feb
No More Genetically Engineered Salmon—In 2016, At Least Morgan, Lewis & Bockius LLP
3
Feb
Food Imports: Risky Business? Keller and Heckman LLP
3
Feb
FDA Issues New Draft Guidance on Postmarket Cybersecurity for Medical Devices Morgan, Lewis & Bockius LLP
2
Feb
FDA Recommends Medical Device Manufacturers Implement a Comprehensive Cybersecurity Risk Management Program in Accordance with NIST Standards Epstein Becker & Green, P.C.
2
Feb
Federal Circuit Holds Defective Restriction Requirement Ends Patent Term Adjustment Sterne, Kessler, Goldstein & Fox P.L.L.C.
2
Feb
“Natural” Seal Appeal - Food Labeling Keller and Heckman LLP
2
Feb
Purdue OxyContin Patents Invalid Despite Stemming From Discovery Of Source Of Toxic Impurity Foley & Lardner LLP
2
Feb
CMS Final Covered Outpatient Drug Rule Addresses Many Industry Concerns Morgan, Lewis & Bockius LLP
1
Feb
FDA Releases Draft Guidance for Medical Device Cybersecurity Mintz
1
Feb
Genetically Modified Food: Deal or No Deal? Keller and Heckman LLP
29
Jan
Labeling GMO’s — Too Late and Too Much Schwegman, Lundberg & Woessner, P.A.
29
Jan
Challenge of Non-Interference Mintz
29
Jan
True Green for True Blue: Blue Buffalo Promises $32 Million Settlement Proskauer Rose LLP
29
Jan
Clarifying the Obscure (Claim Indefiniteness) McDermott Will & Emery

Pages

Advertisement
Advertisement

TRENDING LEGAL ANALYSIS

Advertisement